Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | EVP, Gen. Counsel & Secretary | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 119,024 |
Reported balance
After 2026-09-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-15 · Grant · Acquired 48,076 · Balance 119,024 F1: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting.
F2: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F3: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 17, 2026 21:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 48,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-394488 · ownership.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,024 F1 · acquired: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,491 | $67.26 | $167,553.88 |
DisclosureSEC source: 0001193125-25-323425 · ownership.xml · nonDerivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,563 F9 · price: The shares were sold in multiple transactions at prices ranging from $66.52 to $67.51, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025. F6 · balance_after: Shares held following the reported transactions include 53,636 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,371 | $67.17 | $159,261.26 |
DisclosureSEC source: 0001193125-25-323425 · ownership.xml · nonDerivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,054 F8 · price: The shares were sold in multiple transactions at prices ranging from $67.00 to $67.38, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025. F6 · balance_after: Shares held following the reported transactions include 53,636 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,738 | $66.58 | $448,587.74 |
DisclosureSEC source: 0001193125-25-323425 · ownership.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,425 F7 · price: The shares were sold in multiple transactions at prices ranging from $65.98 to $66.97, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025. F6 · balance_after: Shares held following the reported transactions include 53,636 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 2,530 | $66.62 | $168,548.60 |
DisclosureSEC source: 0001193125-25-323425 · ownership.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,163 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F6 · balance_after: Shares held following the reported transactions include 53,636 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 5,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323425 · ownership.xml · derivative · entry 10 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,915 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F12 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 9,149 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 5,915 PSUs. The remaining 3,234 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. F12 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 9,149 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 5,915 PSUs. The remaining 3,234 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 56,440 | $0.00 Strike: $66.62 | $0.00 |
DisclosureSEC source: 0001193125-25-323425 · ownership.xml · derivative · entry 9 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,440 Underlying: Class A Common Stock · 56,440 shares Expires 2035-12-15 F11 · derivative.exercise_date: This option was granted for a total of 56,440 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 12,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323425 · ownership.xml · derivative · entry 8 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,816 Underlying: Class A Common Stock · 12,816 shares Expires not disclosed F10 · derivative.exercise_price: Each performance-based restricted stock unit ("PSU") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F10 · derivative.exercise_date: Each performance-based restricted stock unit ("PSU") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F10 · derivative.expiration_date: Each performance-based restricted stock unit ("PSU") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 9,252 | $67.54 | $624,880.08 |
DisclosureSEC source: 0001193125-25-323425 · ownership.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,693 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F5 · balance_after: Shares held following the reported transactions include 58,657 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323425 · ownership.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F2 · balance_after: Shares held following the reported transactions include 71,103 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:39 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 25,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-323425 · ownership.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,030 F1 · acquired: Award represents a total of 25,633 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2025. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 71,103 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 18:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001193125-25-307131 · ownership.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,500 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 19,500 shares. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 18:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 4,500 | $67.56 | $304,035.75 |
DisclosureSEC source: 0001193125-25-307131 · ownership.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,397 F2 · price: The shares were sold in multiple transactions at prices ranging from $67.115 to $67.95, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 18:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 4,500 | $64.60 | $290,700.00 |
DisclosureSEC source: 0001193125-25-307131 · ownership.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 19:58 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0000950170-25-083386 · ownership.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,500 Underlying: Class A Common Stock · 15,000 shares Expires 2025-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 19,500 shares. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 19:58 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 15,000 | $75.02 | $1,125,286.50 |
DisclosureSEC source: 0000950170-25-083386 · ownership.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,397 F2 · price: The shares were sold in multiple transactions at prices ranging from $75.00 to $75.125, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 19:58 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 15,000 | $64.60 | $969,000.00 |
DisclosureSEC source: 0000950170-25-083386 · ownership.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 16:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 350 | $74.97 | $26,239.50 |
DisclosureSEC source: 0000950170-25-081036 · ownership.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,397 F1 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares sold in the reported transaction consist of 350 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 20:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0000950170-25-012643 · ownership.xml · derivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,000 Underlying: Class A Common Stock · 40,000 shares Expires 2027-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 56,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 20:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 25,000 | $86.00 | $2,150,102.50 |
DisclosureSEC source: 0000950170-25-012643 · ownership.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,397 F2 · price: The shares were sold in multiple transactions at prices ranging from $86.00 to $86.195, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 20:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 15,000 | $83.00 | $1,245,000.00 |
DisclosureSEC source: 0000950170-25-012643 · ownership.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,397 F1 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 20:29 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 40,000 | $62.32 | $2,492,800.00 |
DisclosureSEC source: 0000950170-25-012643 · ownership.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2024 Filed Dec 18, 2024 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,713 | $78.22 | $603,317.03 |
DisclosureSEC source: 0000950170-24-138158 · ownership.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,397 F7 · price: The shares were sold in multiple transactions at prices ranging from $78.06 to $78.52, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F5 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2024 Filed Dec 18, 2024 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 4,625 | $77.83 | $359,986.41 |
DisclosureSEC source: 0000950170-24-138158 · ownership.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,110 F6 · price: The shares were sold in multiple transactions at prices ranging from $77.02 to $78.015, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F5 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 5,192 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138158 · ownership.xml · derivative · entry 8 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,192 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F10 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 7,378 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 5,192 PSUs. The remaining 2,186 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. F10 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 7,378 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 5,192 PSUs. The remaining 2,186 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 35,307 | $0.00 Strike: $77.91 | $0.00 |
DisclosureSEC source: 0000950170-24-138158 · ownership.xml · derivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,307 Underlying: Class A Common Stock · 35,307 shares Expires 2034-12-16 F9 · derivative.exercise_date: This option was granted for a total of 35,307 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 10,042 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138158 · ownership.xml · derivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,042 Underlying: Class A Common Stock · 10,042 shares Expires not disclosed F8 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F8 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F8 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 8,867 | $79.18 | $702,089.06 |
DisclosureSEC source: 0000950170-24-138158 · ownership.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,735 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F5 · balance_after: Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,192 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138158 · ownership.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F2 · balance_after: Shares held following the reported transactions include 61,483 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:21 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 20,085 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138158 · ownership.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,410 F1 · acquired: Award represents a total of 20,085 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 16, 2024. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 61,483 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 28, 2024 Filed May 30, 2024 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,998 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0000950170-24-066668 · ownership.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,998 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| May 28, 2024 Filed May 30, 2024 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,283 | $79.62 | $181,772.46 |
DisclosureSEC source: 0000950170-24-066668 · ownership.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,325 F2 · balance_after: Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 28, 2024 Filed May 30, 2024 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 1,998 | $62.32 | $124,515.36 |
DisclosureSEC source: 0000950170-24-066668 · ownership.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares include 285 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2024. F2 · balance_after: Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 19, 2023 Filed Dec 19, 2023 19:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,663 | $86.01 | $143,038.29 |
DisclosureSEC source: 0001209191-23-059261 · doc4.xml · nonDerivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,325 F8 · price: The shares were sold in multiple transactions at prices ranging from $85.89 to $86.138, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F6 · balance_after: Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 19:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 8,856 | $86.19 | $763,270.30 |
DisclosureSEC source: 0001209191-23-059261 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,988 F7 · price: The shares were sold in multiple transactions at prices ranging from $85.86 to $86.78, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F6 · balance_after: Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 18, 2023 Filed Dec 19, 2023 19:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,637 | $87.49 | $143,221.13 |
DisclosureSEC source: 0001209191-23-059261 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,844 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F6 · balance_after: Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 5,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059261 · doc4.xml · derivative · entry 9 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F11 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 7,136 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 5,738 PSUs. The remaining 1,398 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. F11 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 7,136 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 5,738 PSUs. The remaining 1,398 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 29,316 | $0.00 Strike: $87.49 | $0.00 |
DisclosureSEC source: 0001209191-23-059261 · doc4.xml · derivative · entry 8 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,316 Underlying: Class A Common Stock · 29,316 shares Expires 2033-12-15 F10 · derivative.exercise_date: This option was granted for a total of 29,316 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 8,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059261 · doc4.xml · derivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,363 Underlying: Class A Common Stock · 8,363 shares Expires not disclosed F9 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F9 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F9 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 8,713 | $88.60 | $771,971.80 |
DisclosureSEC source: 0001209191-23-059261 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,481 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F5 · balance_after: Shares held following the reported transactions include 44,698 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059261 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F2 · balance_after: Shares held following the reported transactions include 56,529 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 19:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 16,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059261 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,456 F1 · acquired: Award represents a total of 16,726 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2023. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 56,529 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 16:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0001209191-23-042270 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,998 Underlying: Class A Common Stock · 21,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 16:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 21,000 | $89.00 | $1,869,000.00 |
DisclosureSEC source: 0001209191-23-042270 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,730 F1 · balance_after: Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 16:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 21,000 | $62.32 | $1,308,720.00 |
DisclosureSEC source: 0001209191-23-042270 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest F2 · balance_after: Shares include 356 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023. Read SEC document |
| May 08, 2023 Filed May 10, 2023 16:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,882 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0001209191-23-028505 · doc4.xml · derivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,998 Underlying: Class A Common Stock · 3,882 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares. Read SEC document |
| May 08, 2023 Filed May 10, 2023 16:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,118 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-23-028505 · doc4.xml · derivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 11,118 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was originally granted for a total of 52,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| May 08, 2023 Filed May 10, 2023 16:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,180 | $84.35 | $183,888.89 |
DisclosureSEC source: 0001209191-23-028505 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,374 F3 · price: The shares were sold in multiple transactions at prices ranging from $84.10 to $84.735, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| May 08, 2023 Filed May 10, 2023 16:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 12,820 | $83.47 | $1,070,025.15 |
DisclosureSEC source: 0001209191-23-028505 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,554 F2 · price: The shares were sold in multiple transactions at prices ranging from $83.07 to $84.015, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| May 08, 2023 Filed May 10, 2023 16:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 3,882 | $62.32 | $241,926.24 |
DisclosureSEC source: 0001209191-23-028505 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.